BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24607147)

  • 21. TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.
    Bagnoli S; Piaceri I; Tedde A; Bessi V; Bracco L; Sorbi S; Nacmias B
    Neurol Sci; 2013 Jun; 34(6):995-8. PubMed ID: 23546992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of association between protocadherin 11-X/Y (PCDH11X and PCDH11Y) polymorphisms and late onset Alzheimer's disease.
    Miar A; Alvarez V; Corao AI; Alonso B; Díaz M; Menéndez M; Martínez C; Calatayud M; Morís G; Coto E
    Brain Res; 2011 Apr; 1383():252-6. PubMed ID: 21276771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.
    Yu CE; Seltman H; Peskind ER; Galloway N; Zhou PX; Rosenthal E; Wijsman EM; Tsuang DW; Devlin B; Schellenberg GD
    Genomics; 2007 Jun; 89(6):655-65. PubMed ID: 17434289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-Exome Sequencing Analysis of Alzheimer's Disease in Non-APOE*4 Carriers.
    Fan KH; Feingold E; Rosenthal SL; Demirci FY; Ganguli M; Lopez OL; Kamboh MI
    J Alzheimers Dis; 2020; 76(4):1553-1565. PubMed ID: 32651314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited.
    Deelen J; Beekman M; Uh HW; Helmer Q; Kuningas M; Christiansen L; Kremer D; van der Breggen R; Suchiman HE; Lakenberg N; van den Akker EB; Passtoors WM; Tiemeier H; van Heemst D; de Craen AJ; Rivadeneira F; de Geus EJ; Perola M; van der Ouderaa FJ; Gunn DA; Boomsma DI; Uitterlinden AG; Christensen K; van Duijn CM; Heijmans BT; Houwing-Duistermaat JJ; Westendorp RG; Slagboom PE
    Aging Cell; 2011 Aug; 10(4):686-98. PubMed ID: 21418511
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    González RD; Gomes I; Gomes C; Rocha R; Durães L; Sousa P; Figueruelo M; Rodríguez M; Pita C; Hornero R; Gómez C; Lopes AM; Pinto N; Martins S
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.
    Barral S; Bird T; Goate A; Farlow MR; Diaz-Arrastia R; Bennett DA; Graff-Radford N; Boeve BF; Sweet RA; Stern Y; Wilson RS; Foroud T; Ott J; Mayeux R;
    Neurology; 2012 May; 78(19):1464-71. PubMed ID: 22539578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.
    Rezazadeh M; Khorrami A; Yeghaneh T; Talebi M; Kiani SJ; Heshmati Y; Gharesouran J
    Neuromolecular Med; 2016 Mar; 18(1):37-49. PubMed ID: 26553058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).
    Nowotny P; Simcock X; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Smemo S; Morris JC; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):469-74. PubMed ID: 17427190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort.
    Alaylıoğlu M; Gezen-Ak D; Dursun E; Bilgiç B; Hanağası H; Ertan T; Gürvit H; Emre M; Eker E; Uysal Ö; Yılmazer S
    J Geriatr Psychiatry Neurol; 2016 Jul; 29(4):221-6. PubMed ID: 27076484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of whole genome sequenced cases and controls shows that the association of variants in
    Curtis D;
    J Neurogenet; 2021; 35(2):59-66. PubMed ID: 33970751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.
    Nicodemus KK; Stenger JE; Schmechel DE; Welsh-Bohmer KA; Saunders AM; Roses AD; Gilbert JR; Vance JM; Haines JL; Pericak-Vance MA; Martin ER
    Neurogenetics; 2004 Dec; 5(4):201-8. PubMed ID: 15455263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
    Zhang C; Hu R; Zhang G; Zhe Y; Hu B; He J; Wang Z; Qi X
    J Mol Neurosci; 2019 Nov; 69(3):433-443. PubMed ID: 31346968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Data mining of high density genomic variant data for prediction of Alzheimer's disease risk.
    Briones N; Dinu V
    BMC Med Genet; 2012 Jan; 13():7. PubMed ID: 22273362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A loss of function variant in CASP7 protects against Alzheimer's disease in homozygous APOE ε4 allele carriers.
    Ayers KL; Mirshahi UL; Wardeh AH; Murray MF; Hao K; Glicksberg BS; Li S; Carey DJ; Chen R
    BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):445. PubMed ID: 27358062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
    Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
    Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.
    Vélez JI; Lopera F; Sepulveda-Falla D; Patel HR; Johar AS; Chuah A; Tobón C; Rivera D; Villegas A; Cai Y; Peng K; Arkell R; Castellanos FX; Andrews SJ; Silva Lara MF; Creagh PK; Easteal S; de Leon J; Wong ML; Licinio J; Mastronardi CA; Arcos-Burgos M
    Mol Psychiatry; 2016 Jul; 21(7):916-24. PubMed ID: 26619808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
    Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
    Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.
    Andrews SJ; Fulton-Howard B; Goate A
    Lancet Neurol; 2020 Apr; 19(4):326-335. PubMed ID: 31986256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association and Gene-Gene Interactions Study of Late-Onset Alzheimer's Disease in the Russian Population.
    Bocharova A; Vagaitseva K; Marusin A; Zhukova N; Zhukova I; Minaycheva L; Makeeva O; Stepanov V
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.